Medpace Holdings CEO August J. Troendle Sells $1.59M in Common Stock

Insider Transaction Overview

On September 25 and September 28, 2026, August J. Troendle, President, CEO, Director, and 10% owner of Medpace Holdings, Inc. (MEDP), executed sales totaling 2,564 shares of Common Stock for an aggregate amount of $1,589,941.10.

Transaction Details Breakdown:

• September 25, 2026: Sold 154 shares directly at a price of $620.60 per share ($95,572.40).
• September 28, 2026: Sold 2,410 shares directly at a volume-weighted average price of $620.07 ($1,494,368.70), ranging from $620.00 to $621.20.

Ownership & Holdings Analysis:

• Direct Ownership After Transactions: 386,892 shares.
• Indirect Ownership: 4,733,019 shares held via Medpace Investors, LLC, where Mr. Troendle acts as the sole manager and controlling unit holder.
• Significance Assessment: While the aggregate proceeds exceed $1.5M, the 2,564 shares sold represent less than 0.06% of Mr. Troendle's total beneficial holdings (>5.1 million shares). The filing notes that the transactions were executed pursuant to a limit order placed during an open trading window rather than a pre-scheduled Rule 10b5-1 plan.